CS
CSCI

Credit Suisse’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Credit Suisse’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2
Closed -$14K – 4615
2014
Q4 		$14K Sell
2
-3
-60% -$25.2K ﹤0.01% 4553
2014
Q3 		$72K Buy
5
+3
+150% +$38.4K ﹤0.01% 4333
2014
Q2 		$26K Sell
2
-1
-33% -$11.2K ﹤0.01% 4624
2014
Q1 		$41K Sell
3
-1
-25% -$12.9K ﹤0.01% 4591
2013
Q4 		$50K Buy
+4
New +$53.2K ﹤0.01% 4530

Other funds holding CSCI

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return

Credit Suisse's CSCI Position: Q1 2015 in Review

Credit Suisse sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2015, closing a stake of 2 shares — an estimated $14K sold.

Credit Suisse first reported a position in CSCI in Q4 2013 and held it in 5 quarters. The position peaked at $72K in Q3 2014. 17 funds tracked by Wall St. Rank hold CSCI as of Q1 2015.

  • Credit Suisse reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Credit Suisse sold 2 COSCIENS Biopharma Inc. Common Stock shares in Q1 2015, an estimated $14K.
  • Credit Suisse first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2013 and held it in 5 quarters.
  • Credit Suisse's COSCIENS Biopharma Inc. Common Stock position peaked at $72K in Q3 2014.
  • 17 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2015.

Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.